RxDoctor Payments Data

Rosalinda Flores

Neurology · McAllen, TXNPI 1366805939

Payments from drug & device makers

$759in general payments, 2019–2025

Across 41 payments — averaging $18.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Supernus Pharmaceuticals, Inc.$157
  • Acorda Therapeutics, Inc$125
  • AstraZeneca$95
  • Eisai Inc.$69
  • Lundbeck LLC$59
  • Adamas Pharmaceuticals, Inc.$43
  • plus $211 from 7 others

What the payments were for

  • Speaking & faculty fees$12517%
  • Food & beverage$63483%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$759 in reported general payments places this provider in the 35th percentile of 1,246 neurology providers in Texas.

See all neurology providers in Texas

Medicare billing

Part B allowed, 2024
$51,045
Medicare patients
207
Services billed
549

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in McAllen

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →